PATENT CLAIM ANALYSIS

Application Number: 15987458
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["544", "237000"]

Abstract:
The present invention relates to a class of substituted triazolopiperazine compounds, tautomers, enantiomers, diastereomers, racemates, metabolites, metabolic precursors, and pharmaceutically acceptable salts, esters, prodrugs or hydrate thereof, a preparation methods therefor, intermediates and a use thereof in the preparation of drugs for prevention and treatment of diseases associated with PARP including various ischemic diseases, neurodegenerative diseases and cancers.

Claim (Index 9):
The use of  claim 8 , said the diseases associated with PARP include various ischemic diseases, neurodegenerative diseases, and cancers; wherein, the ischemic diseases include brain ischemia, ischemic disease of spinal cord, ischemic heart disease, ischemic disease of digestive tube, retinal ischemic disease; neurodegenerative diseases include Parkinson's disease, Alzheimer's disease, muscular dystrophy; and cancers include breast cancer, ovarian cancer, liver cancer, melanoma, prostate cancer, colon cancer, gastric cancer and other solid tumors.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 93.0
- Lexical Diversity: 1.44898
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14418705', '15708917', '13035640', '16060701', '11849230']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8122761433138717
- 35 USC 102 Novelty (BERT): 0.5433813052156284
- Combined Prediction Score: 0.7853866595040474
- Mean Citation Score: 337.94636
- Max Citation Score: 431.5869
- Similarity Product: 259.1704233839214

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test